A collaborative approach with your GP or diabetes specialist nurse ensures that any adjustments to your treatment plan are made safely and appropriately
The qualifying diagnoses (HFpEF, uncontrolled hypertension, CKD, pre-diabetes, prior MI, prior stroke, PAD) are the conditions where GLP-1 trials have shown direct benefit or strong biological plausibility for benefit
Moreover, Lillys main contender, the Danish multinational Novo Nordisk, is investing more than $4 billion in a facility in North Carolina to fill and finish its obesity and diabetes drugs Wegovy and Ozempic, which come in pre-filled pens
: Walter J.H
Consult your healthcare provider for specific guidance
Pregnancy Nutrition: Foods to Avoid During Pregnancy. Mayo Clinic , 2021, U.S